NCT05164016View on ClinicalTrials.gov

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

May 1, 2025

Study Completion Date

December 31, 2027

Conditions

CancerHematopoietic System--CancerTransplant-Related CancerSolid Tumor MalignancyHematologic MalignancySolid Organ TransplantHematopoietic Cell TransplantCellular Therapy

Trial Locations (3)

38103

Le Bonheur, Memphis

LeBonheur, Memphis

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

lead

St. Jude Children's Research Hospital

OTHER